Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,287 | 461 | 97.0% |
| Education | $224.07 | 5 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,511 | 116 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $826.26 | 44 | $0 (2024) |
| ABBVIE INC. | $654.29 | 48 | $0 (2024) |
| Lilly USA, LLC | $629.61 | 34 | $0 (2024) |
| Astellas Pharma US Inc | $393.97 | 13 | $0 (2024) |
| Merck Sharp & Dohme LLC | $369.38 | 28 | $0 (2023) |
| Allergan, Inc. | $339.78 | 25 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $278.15 | 15 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $247.22 | 12 | $0 (2023) |
| GlaxoSmithKline, LLC. | $228.57 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,153 | 55 | Astellas Pharma US Inc ($257.15) |
| 2023 | $963.24 | 53 | Lilly USA, LLC ($178.39) |
| 2022 | $1,088 | 66 | Novo Nordisk Inc ($348.85) |
| 2021 | $1,073 | 73 | Novo Nordisk Inc ($295.29) |
| 2020 | $1,212 | 66 | Novo Nordisk Inc ($267.93) |
| 2019 | $860.78 | 73 | Zyla Life Sciences ($207.35) |
| 2018 | $608.98 | 42 | Novo Nordisk Inc ($145.18) |
| 2017 | $552.48 | 38 | Allergan Inc. ($115.67) |
All Payment Transactions
466 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Biological | ||||||
| 12/16/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: DERMATOLOGY | ||||||
| 12/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $5.15 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.55 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Diabetes Care | ||||||
| 11/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Oncology | ||||||
| 10/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Obesity | ||||||
| 10/15/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: DERMATOLOGY | ||||||
| 10/07/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Oncology | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Respiratory | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Gastroenterology | ||||||
| 09/24/2024 | PFIZER INC. | TRUMENBA (Biological), PREVNAR 20, COMIRNATY | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: VACCINES | ||||||
| 09/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Biological | ||||||
| 08/29/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Hematology | ||||||
| 08/27/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $28.68 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Diabetes Care | ||||||
| 08/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.81 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Diabetes | ||||||
| 07/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.60 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.01 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 235 | 306 | $63,764 | $22,584 |
| 2022 | 7 | 275 | 358 | $72,036 | $23,547 |
| 2021 | 6 | 250 | 350 | $72,190 | $23,879 |
| 2020 | 6 | 244 | 325 | $57,233 | $17,961 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 47 | 47 | $13,728 | $6,067 | 44.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 59 | 107 | $20,437 | $5,368 | 26.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 51 | 74 | $20,424 | $4,990 | 24.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 12 | 12 | $3,300 | $3,234 | 98.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 22 | 22 | $2,200 | $1,582 | 71.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 29 | 29 | $2,175 | $885.08 | 40.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 15 | 15 | $1,500 | $457.80 | 30.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 58 | 58 | $16,994 | $7,690 | 45.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 54 | 91 | $25,116 | $6,029 | 24.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 65 | 111 | $21,201 | $5,953 | 28.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 28 | 28 | $2,800 | $1,919 | 68.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 43 | 43 | $3,225 | $1,265 | 39.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 14 | 14 | $1,400 | $416.10 | 29.7% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 13 | 13 | $1,300 | $274.17 | 21.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 60 | 108 | $29,808 | $8,663 | 29.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 48 | 48 | $14,064 | $6,479 | 46.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 66 | 118 | $22,538 | $6,117 | 27.1% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 24 | 24 | $2,400 | $1,566 | 65.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 39 | 39 | $2,925 | $664.56 | 22.7% |
| 90674 | Vaccine for influenza derived from cell cultures for administration into muscle, 0.5 ml dosage, quadrivalent, , preservative and antibiotic free | Office | 2021 | 13 | 13 | $455.00 | $389.22 | 85.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 57 | 57 | $12,983 | $6,507 | 50.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 65 | 119 | $19,801 | $4,894 | 24.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 58 | 84 | $20,144 | $4,527 | 22.5% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 17 | 17 | $1,700 | $1,012 | 59.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 30 | 31 | $2,010 | $522.76 | 26.0% |
About Dr. Joyce Lewis, M.D
Dr. Joyce Lewis, M.D is a Family Medicine healthcare provider based in Clarkston, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1043214737.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joyce Lewis, M.D has received a total of $7,511 in payments from pharmaceutical and medical device companies, with $1,153 received in 2024. These payments were reported across 466 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($7,287).
As a Medicare-enrolled provider, Lewis has provided services to 1,004 Medicare beneficiaries, totaling 1,339 services with total Medicare billing of $87,971. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Clarkston, GA
- Active Since 06/09/2005
- Last Updated 12/23/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1043214737
Products in Payments
- Ozempic (Drug) $800.67
- FARXIGA (Drug) $554.56
- VRAYLAR (Drug) $547.03
- MOUNJARO (Drug) $328.30
- JANUVIA (Drug) $300.75
- Kerendia (Drug) $247.22
- UBRELVY (Drug) $228.35
- SPRIX (Drug) $220.66
- JARDIANCE (Drug) $214.55
- Rybelsus (Drug) $203.46
- XARELTO (Drug) $159.31
- TRULICITY (Drug) $142.75
- Veozah (Drug) $137.34
- Cologuard Collection Kit (Device) $134.97
- Victoza (Drug) $125.03
- SYMBICORT (Drug) $123.29
- TRELEGY ELLIPTA (Drug) $119.12
- SOLIQUA 100/33 (Biological) $109.84
- XIFAXAN (Drug) $104.91
- Saxenda (Drug) $104.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Clarkston
Dr. Larry Baylis, D.o, D.O
Family Medicine — Payments: $13,475
Dorothy White-Williams, M.d, M.D
Family Medicine — Payments: $7,926
Dr. Katherine French, Do, DO
Family Medicine — Payments: $7,438
Dr. Timothy Oneill, Do, DO
Family Medicine — Payments: $6,524
Dr. Salomi Rami, Do, DO
Family Medicine — Payments: $6,150
Grant Below, Do, DO
Family Medicine — Payments: $6,113